Nektarios Tavernarakis
Current position:
Current position
Chairman of the Board of Directors at the Foundation for Research and Technology-Hellas and Professor of Molecular Systems Biology at the Medical School of the University of Crete, Heraklion, Greece.

Nektarios Tavernarakis is Professor of Molecular Systems Biology at the Medical School of the University of Crete, and is also heading the Neurogenetics and Ageing laboratory of the Institute of Molecular Biology and Biotechnology, at the Foundation for Research and Technology-Hellas, in Heraklion, Greece. He studied Biology at the Aristotle University of Thessaloniki and holds a PhD degree in Molecular Genetics from the University of Crete. His research focuses on the molecular mechanisms of necrotic cell death and neurodegeneration, the interplay between cellular metabolism and ageing, and the mechanisms of sensory transduction and integration by the nervous system. He is an elected member of the European Institute of Innovation and Technology Governing Board, and has served as Director of the Institute of Molecular Biology and Biotechnology. He is a member of the European Molecular Biology Organization, the Academia Europaea, the American Association for the Advancement of Science (AAAS), the German National Academy of Sciences (Leopoldina), the Academy of Athens, and the European Academy of Sciences and Arts. He is the recipient of two ERC Advanced Investigator Grants, an ERC Proof of Concept Grant, and several prizes and awards, including the EMBO Young Investigator award, the Alexander von Humboldt Foundation, Friedrich Wilhelm Bessel research award, the Helmholtz International Fellow Award, the Bodossaki Foundation Scientific Prize for Medicine and Biology, the Empeirikeion Foundation Academic Excellence Prize, and the BioMedical Research Award of the Academy of Athens.

Mandate ERC Scientific Council: 01 Aug 2016 - 31 Dec 2022 (2nd term).

Professor Nektarios Tavernarakis  is Vice-President of the European Research Council since 01 Jan 2021 and is responsible for the Life Sciences domain